Cite
Pinto N, Navarro SL, Rimorin C, et al. Pharmacogenomic associations of cyclophosphamide pharmacokinetic candidate genes with event-free survival in intermediate-risk rhabdomyosarcoma: A report from the Children's Oncology Group. Pediatr Blood Cancer. 2021;68(11):e29203doi: 10.1002/pbc.29203.
Pinto, N., Navarro, S. L., Rimorin, C., Wurscher, M., Hawkins, D. S., & McCune, J. S. (2021). Pharmacogenomic associations of cyclophosphamide pharmacokinetic candidate genes with event-free survival in intermediate-risk rhabdomyosarcoma: A report from the Children's Oncology Group. Pediatric blood & cancer, 68(11), e29203. https://doi.org/10.1002/pbc.29203
Pinto, Navin, et al. "Pharmacogenomic associations of cyclophosphamide pharmacokinetic candidate genes with event-free survival in intermediate-risk rhabdomyosarcoma: A report from the Children's Oncology Group." Pediatric blood & cancer vol. 68,11 (2021): e29203. doi: https://doi.org/10.1002/pbc.29203
Pinto N, Navarro SL, Rimorin C, Wurscher M, Hawkins DS, McCune JS. Pharmacogenomic associations of cyclophosphamide pharmacokinetic candidate genes with event-free survival in intermediate-risk rhabdomyosarcoma: A report from the Children's Oncology Group. Pediatr Blood Cancer. 2021 Nov;68(11):e29203. doi: 10.1002/pbc.29203. Epub 2021 Jul 10. PMID: 34245211; PMCID: PMC8719493.
Copy
Download .nbib